financetom
Business
financetom
/
Business
/
RBC Previews Canadian Lifecos Q3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC Previews Canadian Lifecos Q3
Oct 17, 2025 10:50 AM

01:21 PM EDT, 10/17/2025 (MT Newswires) -- The Canadian lifecos begin reporting third-quarter results on Nov. 4.

RBC Capital is making modest changes across its lifeco models, with core EPS estimates increasing 2.5% on average, reflecting an average ~2% QoQ and ~8% YoY increase.

Great-West Lifeco's ( GWLIF ) quarter should be similar to last quarter (i.e., solid). "Our base EPS estimate slightly increases and we forecast its base EPS to decrease ~3% QoQ but increase ~5% YoY." GWO is rated Sector Perform, with a $53 price target.

IAG's quarter should benefit from strong equity markets and in analyst Darko Mihelic's view, will likely be the strongest of the group. Core EPS estimate rises by 3%. IAG is rated Sector Perform, with a $151 target.

Manulife's quarter, if it can avoid some "bad luck", should once again show solid profitability. RBC's core EPS estimate increases by ~7%. "We expect its core EPS to increase ~10% QoQ and ~5% YoY." Manulife is rated Outperform, with a $49 target.

Sun Life's third-quarter may still showcase subdued U.S. earnings. "[W]e lower our underlying EPS estimate by ~1% and we expect its underlying EPS to increase ~2% QoQ and ~4% YoY." Sun Life is rated Outperform, with an $84 price target.

"We still see good value in SLF and MFC as we expect earnings and ROE to rebound in 2026 while capital levels remain elevated."

We adjust our models modestly into Q3/25 reporting and our core EPS estimates increase by an average of ~2%. In Q3/25, we expect core EPS to increase ~2% QoQ and ~8% YoY on average for the large Canadian lifecos. Based on our tracked funds, we expect average retail AUM increases but retail net outflows for all the lifecos we track. Based on historical dividend cadences, we expect SLF to declare a $0.03 dividend increase per common share this quarter.

Price: 57.74, Change: -1.04, Percent Change: -1.77

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UBS 'bang on target' with Credit Suisse integration, IT chief says
UBS 'bang on target' with Credit Suisse integration, IT chief says
Oct 9, 2024
ZURICH (Reuters) - UBS's integration of former rival Credit Suisse's clients and data with its own platforms is bang on target after a successful test run, its tech chief told Reuters. UBS CEO Sergio Ermotti has previously flagged that IT integration is one of the biggest risks facing UBS as it embarks on the second, trickier phase of merging with...
Ibex Expands Call Center Operations in Honduras
Ibex Expands Call Center Operations in Honduras
Oct 10, 2024
01:19 PM EDT, 10/08/2024 (MT Newswires) -- Ibex (IBEX) said Tuesday it has added nearly 10,000 square feet to call center facility in Tegucigalpa, Honduras. The company said the addition increased the capacity by 35% with over 180 new production seats. The expanded operations are expected to create nearly 250 jobs. The expanded facility became operational in mid-September, and Ibex...
GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits
GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits
Oct 9, 2024
(Reuters) - Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits that claimed its discontinued heartburn drug Zantac caused cancer. The agreement, announced on Wednesday, resolved 80,000 or 93% of the pending cases against the company in the U.S. and was far...
Viking Therapeutics Unusual Options Activity
Viking Therapeutics Unusual Options Activity
Oct 10, 2024
Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics ( VKTX ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Copyright 2023-2026 - www.financetom.com All Rights Reserved